Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -11.26M
March 31, 2026 -12.27M
December 31, 2025 -9.041M
September 30, 2025 -8.603M
June 30, 2025 -9.923M
March 31, 2025 -11.26M
December 31, 2024 -9.208M
September 30, 2024 -10.37M
June 30, 2024 -12.60M
March 31, 2024 -5.661M
December 31, 2023 -12.89M
September 30, 2023 -10.96M
June 30, 2023 -10.79M
March 31, 2023 -12.03M
December 31, 2022 -9.979M
September 30, 2022 -10.71M
June 30, 2022 -12.74M
Date Value
March 31, 2022 -10.86M
December 31, 2021 -8.619M
September 30, 2021 -8.266M
June 30, 2021 -8.255M
March 31, 2021 -8.136M
December 31, 2020 -7.79M
September 30, 2020 -7.703M
June 30, 2020 -6.081M
March 31, 2020 -7.22M
December 31, 2019 -6.532M
September 30, 2019 -4.666M
June 30, 2019 -5.261M
March 31, 2019 -5.966M
December 31, 2018 -7.391M
September 30, 2018 -2.806M
June 30, 2018 -5.924M
March 31, 2018 -4.971M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 920.00M
AngioDynamics, Inc. -7.097M
Alphatec Holdings, Inc. -25.78M
AtriCure, Inc. 8.955M
Baxter International, Inc. 135.00M